Hospice Care in Omaha, NE
12 Hospice found. Showing 1 - 12
 Chi Health At Home - Omaha Medicare Approved Location: 7415 Cedar Street, Omaha, Nebraska 68124 Phone: (402) 898-8000 |
Visiting Nurse Assn. Of The Midlands Hospice Medicare Approved Location: 12565 West Center Road, Suite 100, Omaha, Nebraska 68144 Phone: (402) 342-5566 |
Methodist Home Health Hospice Medicare Approved Location: 8601 West Dodge Road Suite 138, Omaha, Nebraska 68114 Phone: (402) 354-3200 |
St. Joseph Villa Homecare & Hospice Medicare Approved Location: 1000 N 90th Street Suite 203, Omaha, Nebraska 68114 Phone: (402) 926-4444 |
Endless Journey, Llc Medicare Approved Location: 10909 Mill Valley Rd Suite 205, Omaha, Nebraska 68154 Phone: (402) 670-9501 |
Aseracare Hospice Medicare Approved Location: 8710 Frederick, Suite 100, Omaha, Nebraska 68124 Phone: (402) 926-2680 |
Kindred Hospice Medicare Approved Location: 444 Regency Parkway Drive, Suite 200, Omaha, Nebraska 68114 Phone: (402) 397-0990 |
Compassionate Care Hospice Medicare Approved Location: 7253 Grover Street, Omaha, Nebraska 68124 Phone: (402) 390-2492 |
Progressive Home Health & Hospice Llc Medicare Approved Location: 10040 Regency Circle, Suite 330, Omaha, Nebraska 68114 Phone: (402) 933-5836 |
Pathways To Compassion, Llc Medicare Approved Location: 287 N 115th Street, Omaha, Nebraska 68154 Phone: (402) 333-3149 |
St. Croix Hospice, Llc Medicare Approved Location: 11207 West Dodge Rd, Suite 250, Omaha, Nebraska 68154 Phone: (402) 609-4818 |
Serene Care Incorporated Medicare Approved Location: 4905 S 107th Ave Suite 205, Omaha, Nebraska 68127 Phone: (402) 597-2585 |
News Archive
Carnegie Mellon study identifies intermediary neuron system that acts as synaptic cloaking device
Neuroscientists believe that the connectome, a map of each and every connection between the millions of neurons in the brain, will provide a blueprint that will allow them to link brain anatomy to brain function. But a new study from Carnegie Mellon University has found that a specific type of neuron might be thwarting their efforts at mapping the connectome by temporarily cloaking the synapses that link a wide field of neurons.
Kamada commences enrollment in European inhaled AAT clinical trial for alpha-1 antitrypsin deficiency
Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has enrolled the first patient into its pivotal clinical trial with its new breakthrough compound of inhaled alpha-1 antitrypsin (AAT) delivered by an Investigational eFlow Nebulizer System (PARI Pharma GmbH), in patients with alpha-1 antitrypsin deficiency.
Mysterious polio-like illness baffles medical experts while frightening parents
A spike in the number of children with a rare neurological disease that causes polio-like symptoms has health officials across the country scrambling to understand the illness. Yet, more than four years after health officials first recorded the most recent uptick in cases, much about the national outbreak remains a mystery.
Kiadis five-year follow-up phase I/II clinical study confirms long-term safety, efficacy of ATIR
Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that the five-year follow-up of patients with high-risk malignancies from its Phase I/II clinical study confirms long-term safety and efficacy of ATIR™ over a broad dose range.
› Verified 3 days ago